Toyota's gasoline-electric hybrid models are in high demand worldwide, causing significant shortages and long wait times for buyers. Due to this surge, parts suppliers are struggling to keep up, leading to delays of up to several months in markets like the U.S., Japan, China, and Europe. In Europe, customers are waiting up to 70 days for popular models like the Yaris Cross hybrid and RAV4 plug-in hybrid, a sharp increase from previous years.
Global hybrid sales have almost tripled in the last five years, with sales reaching 16.1 million, confirming Toyota’s successful bet on hybrid technology over battery-only electric vehicles (EVs). However, the strong demand is stretching Toyota's production capacity. A shortage of key components, such as magnets for hybrid motors and inverters, is contributing to these delays, especially with major suppliers like Aisin and Denso facing bottlenecks.
To address this, Toyota is adding manufacturing capacity in India, aiming to produce an additional 132,000 vehicles annually. It has also invested $14 billion in a North Carolina battery plant to meet North American hybrid demand. Meanwhile, competitors like Hyundai and Kia are also grappling with hybrid production delays due to limited capacity.
While these supply challenges persist, hybrids continue to offer a fuel-efficient alternative to traditional vehicles, with many customers willing to wait for delivery due to the significant fuel savings they provide. As Toyota works to streamline its production, the company remains committed to meeting global demand for its hybrid vehicles.


Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Elon Musk’s SpaceX Explores Merger Options With Tesla or xAI, Reports Say
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate
Saks Global to End Saks on Amazon Partnership Amid Bankruptcy Restructuring
Apple Earnings Beat Expectations as iPhone Sales Surge to Four-Year High
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
OpenAI Reportedly Eyes Late-2026 IPO Amid Rising Competition and Massive Funding Needs 



